Literature DB >> 18618550

Effect of temperature on nucleotide pools and monoclonal antibody production in a mouse hybridoma.

N Barnabé1, M Butler.   

Abstract

The specific monoclonal antibody productivity (q(Mab)) of a murine hybridoma (CC9C10) increased with incubation temperature in the range 33 degrees C to 39 degrees C. q(Mab) was constant at each temperature and was independent of the phase of culture. The q(Mab) increased 97% at 39 degrees C and decreased by 21% at 33 degrees C compared with controls at 37 degrees C. Specific rates of substrate (glucose and glutamine) utilization and byproduct (lactate and ammonia) formation also increased with temperature but the yield coefficient, Y(Lac/Llc') was constant for 33 degrees C to 39 degrees C and Y(Amm/Gin) was constant for 37 degrees C to 39 degrees C. Y(Amm/Gin) at 33 degrees C was lower than the control. Changes in specific nucleotide concentrations and ratios were monitored by analysis of intracellular nucleotide pools. The NTP ratio, (ATP + GTP)/(UTP + CTP), increased and the U-ratio (UTP/UDP-GNac) decreased during the course of each culture, whereas the adenylate energy charge, (ATP + 0.5ADP)/(ATP + ADP + AMP), remained relatively constant at a value 0.8. The relative content of UDP-/N acetyl galactosamine, UDP-N acetyl glucosamine, and NAD increased with incubation temperature, whereas the relative ATP content, SA(ATP + ADP + AMP)/SU (UTP + UDP-sugars) ratio, purine/pyrimidine, ATP/GTP, and U-ratio decreased at higher incubation temperatures. It is possible that these nucleotide parameters may have a regulatory role in the changes of q(Mab) observed at the higher temperatures. (c) 1994 John Wiley & Sons, Inc.

Entities:  

Year:  1994        PMID: 18618550     DOI: 10.1002/bit.260441011

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  8 in total

1.  Effects of temperature shift on cell cycle, apoptosis and nucleotide pools in CHO cell batch cultues.

Authors:  A Moore; J Mercer; G Dutina; C J Donahue; K D Bauer; J P Mather; T Etcheverry; T Ryll
Journal:  Cytotechnology       Date:  1997-01       Impact factor: 2.058

2.  On-line immunoanalysis of monoclonal antibodies during a continuous culture of hybridoma cells.

Authors:  J J van der Pol; M Machnik; M Biselli; T Portela-Klein; C D de Gooijer; J Tramper; C Wandrey
Journal:  Cytotechnology       Date:  1997-05       Impact factor: 2.058

3.  Metabolic rates, growth phase, and mRNA levels influence cell-specific antibody production levels from in vitro-cultured mammalian cells at sub-physiological temperatures.

Authors:  Rosalyn J Marchant; Mohamed B Al-Fageeh; Michele F Underhill; Andrew J Racher; C Mark Smales
Journal:  Mol Biotechnol       Date:  2008-02-06       Impact factor: 2.695

4.  The effect of glucose and glutamine on the intracellular nucleotide pool and oxygen uptake rate of a murine hybridoma.

Authors:  N Barnabé; M Butler
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

5.  The inhibitory effect of glutamate on the growth of a murine hybridoma is caused by competitive inhibition of the x(-) (C) transport system required for cystine utilization.

Authors:  E R Broadhurst; M Butler
Journal:  Cytotechnology       Date:  2000-01       Impact factor: 2.058

6.  The effect of the catalytic topoisomerase II inhibitor dexrazoxane (ICRF-187) on CC9C10 hybridoma viability and productivity.

Authors:  N Barnabé; M Butler; B B Hasinoff
Journal:  Cytotechnology       Date:  2001-10       Impact factor: 2.058

7.  Enhancing Protein Expression in HEK-293 Cells by Lowering Culture Temperature.

Authors:  Chi-Yen Lin; Zhen Huang; Wei Wen; Andrew Wu; Congzhou Wang; Li Niu
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

8.  Augmenting recombinant antibody production in HEK293E cells: optimizing transfection and culture parameters.

Authors:  Zealyn Shi-Lin Heng; Joshua Yi Yeo; Darius Wen-Shuo Koh; Samuel Ken-En Gan; Wei-Li Ling
Journal:  Antib Ther       Date:  2022-01-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.